Years of life lost (YLL) from cancer is an important measure of population burden--and should be considered when allocating research funds.

Burnet NG, Jefferies SJ, Benson RJ, Hunt DP, Treasure FP. · 2005

Read Years of life lost (YLL) from cancer is an important measure of population burden--and should be considered when allocating research funds. by Burnet NG, Jefferies SJ, Benson RJ, Hunt DP, Treasure FP. (2005) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc2361853.txt.

Description

Burnet and colleagues argued in 2005 that cancer research money should be judged against years of life lost, not just deaths. Years of life lost adds up how many years each death cuts short. A cancer killing young people scores far higher than one killing mostly the very old.

They compared 17 cancer sites in Britain, where the national research budget was about 250 million pounds. On this measure, cancers of the ovary, cervix, and brain looked much bigger burdens than raw death counts suggest. Brain tumor patients lost the most life each, just over 20 years on average, while prostate cancer lost the least, at 6.1 years per death. Lung cancer stayed underfunded on both measures. Brain, cervix, kidney cancers and melanoma stood out as high-burden but low-spending sites.

Catalog record

CREATORBurnet NG, Jefferies SJ, Benson RJ, Hunt DP, Treasure FP.
YEAR2005
COLLECTIONPAPERS
FORMATTXT
FILE SIZE16 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC2361853

Browse the full library · About the Tower of Babel